His practice covers a broad variety of matters, including assisting leading U.S., European and Asian companies from a wide range of industries, including pharmaceuticals, consumer electronics, chemicals, transportation, automotive and financial institutions in antitrust investigations (cartels and abuses of dominant position), merger control reviews and foreign investment reviews. Charles also assists clients in the application of the new EU Foreign Subsidies regulation.
Charles has been involved in obtaining European Commission clearance in a number of precedent-setting and complex merger cases, and has also advised on a number of cartel and behavioral investigations by the European Commission and other national competition authorities.
Given the importance of China for our clients, he was based in Beijing from 2014 to 2018. During that time, Charles has gained considerable experience in advising multinational companies on merger filings with China’s State Administration for Market Regulation (SAMR) and general issues regarding compliance with China’s Anti-Monopoly Law. He has also developed an expertise in advising SOEs, on regulatory issues arising from their investment in Europe